Jiangsu Nhwa Pharmaceutical
-
Chesterbrook-Based Trevena Receives Milestone Payment from Licensing Partner in China
After the FDA approved its new pain medication, Olinvyk, earlier this month, Chesterbrook-based Trevena has received a $3 million milestone payment from its licensing partner…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
